Carboplatin Hypersensitivity Reactions

Debra L. Winkeljohn

Martha Polovich
CJON 2007, 10(5), 595-598. DOI: 10.1188/06.CJON.595-598

Jump to a section

    References

    Anand, M.K., & Routes, J.M. (2004). Hypersensitivity reactions, immediate. Retrieved August 10, 2005, from http://www.emedicine.com/med/topic1101.htm
    Cleri, L.B., & Haywood, R. (2002). Oncology pocket guide to chemotherapy. Philadelphia: Mosby.
    De Maria, C., Lebel, D., Desroches, A., & Gauvin, F. (2002). Simple intravenous antimicrobial desensitization method for pediatric patients. American Journal of Health-System Pharmacy, 59, 1532-1536.
    Dizon, D.S., Sabbatini, P.J., Aghajanian, C., Hensley, M.L., & Spriggs, D.R. (2002). Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy. Gynecologic Oncology, 84, 378-382.
    Johnson, R.F., & Peebles, R.S. (2004). Anaphylactic shock: Pathophysiology, recognition, and treatment. Seminars in Respiratory and Critical Care Medicine, 25, 695-703.
    Jones, R., Ryan, M., & Friedlander, M. (2003). Carboplatin hypersensitivity reactions: Re-treatment with cisplatin desensitization. Gynecologic Oncology, 89, 112-115.
    Markman, M., Kennedy, A., Webster, K., Elson, P., Peterson, G., Kulp, B., et al. (1999). Clinical features of hypersensitivity reactions to carboplatin. Journal of Clinical Oncology, 17, 1141-1145.
    Markman, M., Zanotti, K., Peterson, G., Kulp, B., Webster, K., & Belinson, J. (2003). Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. Journal of Clinical Oncology, 21, 4611-4614.
    Meyer, L., Zuberbier, T., Worm, M., Oettle, H., & Riess, H. (2002). Hypersensitivity reactions to oxaliplatin: Cross-reactivity to carboplatin and the introduction of a desensitization schedule [Letter to the editor]. Journal of Clinical Oncology, 20, 1146-1147.
    Polyzos, A., Tsavaris, N., Kosmas, C., Arnaouti, T., Kalahanis, N., Tsigris, C., et al. (2001). Hypersensitivity reactions to carboplatin administration are common but not always severe: A 10-year experience. Oncology, 61(2), 129-133.
    Robinson, J.B., Singh, D., Bodurka-Bevers, D.C., Wharton, J.T., Gershenson, D.M., & Wolf, J.K. (2001). Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies. Gynecologic Oncology, 82, 550-558.
    Sood, A.K., Gelder, M.S., Huang, S.W., & Morgan, L.S. (1995). Anaphylaxis to carboplatin following multiple previous uncomplicated courses. Gynecologic Oncology, 57, 131-132.
    Spratto, G.R., & Woods, A.L. (2003). PDR: Nurse's drug handbook. Clifton Park, NY: Delmar.
    Weidmann, B., Mulleneisen, N., Bojko, P., & Niederle, N. (1994). Hypersensitivity reactions to carboplatin: Report of two patients, review of the literature, and discussion of diagnostic procedures and management. Cancer, 73, 2218-2222.
    Weiss, R.B., Donehower, R.C., Wiernik, P.H., Ohnuma, T., Gralla, R.J., Trump, D.L., et al. (1990). Hypersensitivity reactions from Taxol. Journal of Clinical Oncology, 8, 1263-1268.
    Zanotti, K.M., Rybicki, L.A., Kennedy, A.W., Belinson, J.L., Webster, K.D., Kulp, B., et al. (2001). Carboplatin skin testing: A skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. Journal of Clinical Oncology, 19, 3126-3129.
    Zweizig, S., Roman, L.D., & Muderspach, L.I. (1994). Death from anaphylaxis to cisplatin: A case report. Gynecologic Oncology, 53, 121-122.